Jiménez Socorro, Antonio NicolásMartín, AfonsoBernardi Villavicencio, CristinaJiménez Heras, MariaRojo Salvador, ConcepciónRobles Sanmartin, JavierRodríguez Quirós, Jesús2021-03-082021-03-082018000-000-000-00000-0000http://www.mikromed4vet.eu/12-15-september-2018-5th-world-veterinary-orthopaedic-congress-esvot-vos-barcelona-spain/Osteosarcoma (OSA) is the most common bone tumour in Dogs and in giant breeds it’s commonly located in distal radius. Treatment includes: surgery (limb amputation or limb-sparing surgery), radiotherapy and chemotherapy. Amputation is a first-line procedure, it increases survival, brings pain relief thereby delays euthanasia. But limb amputation in giant breeds decreases life quality so limb-sparing surgery can be considered as a good option of treatment. New porous titanium developed by Instituto Tecnológico de Canarias (ITC) can be use as bone substitute in combination with a stabilized plate It has been described that titanium endoprosthesis with limb salvage does not affect survival and provides some advantages over traditional amputation, for OSA treatment.1,3,4 Premature resection of distal radius osteosarcoma and implantation of ITC porous titanium endoprosthesis can be an acceptable option of treatment for the distal radius OSA in dogs, as it increases a quickly return to normal limb function and life quality.es-ESEndoprosthesisOsteosarcomaDogsARTÍCULO DE CONFERENCIA